CD274 and non-small cell lung carcinoma: The National Health Insurance program of Taiwan covers immunotherapy only for those cancer types, including melanoma, NSCLC, urothelial carcinoma, and head and neck squamous cell carcinomas, that meet the PD-L1 expression criteria (Lee et al., 2022).